Get Mobile to Save Time and Money

Health care is going mobile more than ever before and BioPlus is meeting this mobile challenge. By the end of this year, the mobile health app marketplace is expected to reach $26 billion as consumers increasingly turn to mobile application solutions to manage healthcare. Both patients and doctors are on-board with mobile health-related apps. A…

A Broader Perspective

Medication non-adherence gets a lot of attention – and for good reason since non-adherence contributes to unfavorable patient outcomes, unnecessary hospitalizations, and even patient mortality – yet non-adherence is not the only important medication issue deserving attention from the health care team. In fact, some experts now suggest that medication non-adherence is just the tip…

Sticking Points

There are several ‘sticking points’ that get in the way of patients sticking with their prescribed treatment. In fact, medication nonadherence remains a key area of wasted health care resources. A recent article in the Journal of Managed Care and Specialty Pharmacy points out that there are two types of medication nonadherence: Primary Nonadherence: when…

Pharmacist-Led, Patient-Centered Care

The “usual care” for most patients with a chronic disease is management of the condition by a health care provider. A new model of chronic disease management might make more sense, at least for some patients. When a clinical pharmacist heads up the care team, patients actually show improved outcomes and better access to health…

Smoothing the Path

Medication adherence continues to be a challenge for the health care community. Successful treatment of disease simply cannot occur if patients are not adherent to medications. In addition, non-adherence leads to systemic waste. For example, up to 10% of all money spent on health care is attributed to avoidable health care costs linked to nonadherence….

Rely on Pharmacists

Have you heard about the new Medicare Access and CHIP Reauthorization Act (MACRA)? This new law will go into effect in 2019, changing the way reimbursement works for many physician offices. In short: to receive reimbursement from Medicare, offices will have to either: Use an alternative payment model (such as the patient-centered medical home) Or…

Compliance in the Long Haul

Treating cancer is not always about a cure, sometimes it is more realistic to aim for controlling it long term as a chronic condition, which is a topic I explored earlier this year in Cancer Cure Vs. Control. It can be appropriate in some cases to control cancer with the goal of keeping it from…

What If A Pill Doesn’t Make It Easier?

At first glance, it would seem like a slam-dunk idea: improve patient medication adherence by switching from an injectable medication to an oral one. An easy-to-swallow pill must be better than an uncomfortable needle stick, one would assume. Yet this is not necessarily the case. For example, with multiple sclerosis, many patients actually stick to…

Staying With the Patient

Medication adherence issues account for a significant portion of avoidable health care costs each year, through drug waste, treatment failure, and medical complications. Identifying ways to improve adherence ripples out positively throughout the health care system – benefiting the patient, payers, and all other key players. The pharmacy model at BioPlus Specialty Pharmacy focuses on…

Making Assumptions

Many physicians would likely be surprised to learn that their patients are not as faithful at taking important medications as they think. Medication adherence continues to be a drain on optimal treatment outcomes for serious diseases. HealthPrize Technologies, an industry-leading medication adherence and digital patient engagement company, recently surveyed physicians about adherence. The physicians surveyed…

Stick With It

A cure for multiple sclerosis (MS) remains elusive, although there are numerous disease modifying treatments available which aim to calm inflammation and lengthen the time between relapses. Not surprisingly, patients with the most faithful use of their prescriptions have the fewest relapses, says a new study of MS adherence published in the journal Multiple Sclerosis…

After the Cure, Expect Many Years

Life after hepatitis C can be sweet, indeed. A patient who achieves a sustained viral response (SVR), which is another term meaning they are cured of the hepatitis C infection, can expect a lifespan just as long as someone who never had this disease. The year just keeps getting better and better for those with…

The Multiple Forms of Multiple Sclerosis

Elvin Montanez, Pharm.D., Senior Vice President at BioPlus Specialty Pharmacy Multiple sclerosis (MS) can be a tough disease to diagnose, since its symptoms can be mistaken for other conditions. Even after this autoimmune disease is ID’ed, that may not be the end of the story. Today, experts are starting to understand that there is more…

Making Decisions Together: Bringing Patients Into the Conversation

It is much more important to know what sort of a patient has a disease than what sort of a disease the patient has. — William Osler, M.D., 1913 Understanding the patient being treating can sometimes make more difference to treatment outcomes than knowing which disease is being treated. This nugget of wisdom, noted above…

A Special Touch

Brittany Trane knew that she’d really found the right place to work, soon after starting at BioPlus Specialty Pharmacy. One of the first patients she interacted with was Craig*, a patient with multiple sclerosis, who had been prescribed a new medication, called Rebif®. Rebif is used in the relapsing form of multiple sclerosis, to decrease…

Patient Adherence Goes Up as Out-of-Pocket Costs Go Down

The sky-rocketing cost of healthcare certainly isn’t breaking news. There is, however, an unfortunate trend related to these rising fees. As costs increasingly shift from payers onto the patients themselves – through greater out-of-pocket costs – finances for some patients hit a threshold which impacts adherence. In other words, some patients are simply getting priced…

Patient Assistance Lends a Hand

Specialty pharmacy continues to see annual increases in terms of U.S. spending on prescriptions for the treatment of complex or chronic diseases. URAC estimates that specialty drugs account for more than $50 billion of U.S. drug expenditures and comprises nearly 20 percent of the total pharmaceutical revenue. Specialty pharmacy is expected to make up approximately…

Hepatitis C Blues

Hepatitis C and depression tend to go hand-in-hand. For starters, there is the psychological impact of being diagnosed with a life-threatening disease. But with hepatitis C, the situation gets trickier. Certain medications used in the treatment of hepatitis C – which are needed to clear the virus and avoid cirrhosis, liver cancer, and death –…